National Vision
EYE
16.82
+0.08
+0.48%
National Vision
US · EYE
#3082 by market cap
Listed 2017
16.82
+0.08
+0.48%
Live - 5344 symbols - heartbeat 368s ago
· 2026-10-07 20:02
After-hours
16.82
0.00%
- Market cap
- 1.33B
- P/E (TTM)i
- 27.13
- P/Bi
- 1.48
- EPSi
- 0.37
- Div yieldi
- 0.00%
- 52W posi
- 14%
Reader sentiment
Are you bullish or bearish on EYE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.89, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.00% YoY
Margins
- Gross margin
- 58.77%
- Operating margin
- 3.06%
- Net margin
- 1.49%
Key ratios & quality
- Enterprise valuei
- 1.62B
- Altman Z-Scorei
- 1.89
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.54B | 1.72B | 1.71B | 2.08B | 1.64B | 1.76B | 1.82B | 1.99B |
| Gross profit | 823.28M | 917.81M | 925.14M | 1.17B | 977.01M | 1.02B | 1.06B | 1.17B |
| Selling & admin expenses | 687.48M | 744.49M | 724.99M | 900.80M | 832.61M | 904.76M | 938.52M | 1.02B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 59.98M | 82.47M | 109.01M | 179.36M | 58.27M | 27.19M | 29.49M | 60.82M |
| Pretax profit | 4.87M | 30.49M | 38.68M | 149.33M | 52.30M | 9.55M | -25.68M | 41.68M |
| Tax | -18.79M | -2.31M | 2.40M | 21.08M | 15.55M | 6.01M | 1.48M | 12.08M |
| Net profit | 23.65M | 32.80M | 36.28M | 128.24M | 42.12M | -65.90M | -28.50M | 29.60M |
| Basic EPS | 0 | 0 | 0 | 2 | 1 | -1 | 0 | 0 |
| Diluted EPS | 0.30 | 0.40 | 0.44 | 1.43 | 0.52 | -0.84 | -0.36 | 0.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 510.32M | 486.42M | 487.33M | 503.41M | 543.88M | 498.81M |
| Gross profit | 305.13M | 286.05M | 284.13M | 292.70M | 324.74M | 290.43M |
| Selling & admin expenses | 255.53M | 247.17M | 252.34M | 261.21M | 256.09M | 243.43M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 26.64M | 16.45M | 9.61M | 8.12M | 45.24M | 23.81M |
| Pretax profit | 21.57M | 12.24M | 5.49M | 2.39M | 42.39M | 17.97M |
| Tax | 7.38M | 3.51M | 2.12M | -929.00K | 11.21M | 5.55M |
| Net profit | 14.19M | 8.73M | 3.37M | 3.32M | 31.18M | 12.42M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.18 | 0.11 | 0.04 | 0.04 | 0.38 | 0.15 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 214.70M | 234.64M | 566.65M | 514.58M | 473.84M | 396.67M | 249.83M | 225.72M |
| Cash & ST investments | 17.13M | 39.34M | 373.90M | 305.80M | 229.43M | 149.90M | 73.95M | 38.71M |
| Inventory | 116.02M | 127.56M | 111.27M | 123.67M | 123.16M | 119.91M | 93.92M | 89.32M |
| Total assets | 1.66B | 2.03B | 2.33B | 2.29B | 2.29B | 2.17B | 2.01B | 1.98B |
| Total current liabilities | 211.65M | 273.18M | 328.68M | 343.80M | 344.26M | 397.70M | 468.27M | 412.41M |
| Short-term debt | 7.57M | 65.70M | 61.95M | 64.93M | 81.32M | 95.57M | 201.09M | 106.90M |
| Long-term debt | 548.63M | 525.90M | 624.61M | 543.57M | 563.39M | 437.68M | 239.15M | 223.24M |
| Total liabilities | 918,235,000.00 | 1,256,288,000.00 | 1,426,996,000.00 | 1,367,111,000.00 | 1,390,133,000.00 | 1,343,093,000.00 | 1,191,438,000.00 | 1,114,145,000.00 |
| Total equity | 743.15M | 776.44M | 906.50M | 925.98M | 901.11M | 829.42M | 816.33M | 869.53M |
| Retained earnings | 74.84M | 107.13M | 142.88M | 278.40M | 320.52M | 254.62M | 226.12M | 255.72M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 254.12M | 217.70M | 220.19M | 225.72M | 260.62M | 226.89M |
| Cash & ST investments | 80.02M | 48.47M | 56.03M | 38.71M | 67.90M | 36.00M |
| Inventory | 88.57M | 89.65M | 88.01M | 89.32M | 107.71M | 122.59M |
| Total assets | 2.01B | 1.97B | 1.96B | 1.98B | 2.02B | 1.98B |
| Total current liabilities | 468.21M | 418.25M | 416.97M | 412.41M | 418.49M | 383.03M |
| Short-term debt | 202.19M | 119.00M | 119.23M | 106.90M | 107.94M | 110.60M |
| Long-term debt | 244.65M | 255.62M | 236.51M | 223.24M | 225.25M | 221.29M |
| Total liabilities | 1,174,192,000.00 | 1,117,771,000.00 | 1,099,711,000.00 | 1,114,145,000.00 | 1,122,477,000.00 | 1,086,497,000.00 |
| Total equity | 836.16M | 850.58M | 858.76M | 869.53M | 898.01M | 897.00M |
| Retained earnings | 240.30M | 249.03M | 252.40M | 255.72M | 286.90M | 299.31M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 106.63M | 165.08M | 234.98M | 258.94M | 119.20M | 173.03M | 133.65M | 146.29M |
| Depreciation & amortization | 74.34M | 87.24M | 91.59M | 101.80M | 105.97M | 101.42M | 99.08M | 99.89M |
| Free cash flow | 2.14M | 63.76M | 158.16M | 163.42M | 5.65M | 58.26M | 38.14M | 73.45M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.93M | -10.88M | 12.42M | -61.46M | -80.64M | -26.58M | -1.59M | 190.00K |
| Ending cash balance | 18.00M | 40.31M | 375.16M | 306.88M | 230.62M | 151.03M | 75.24M | 40.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 32.24M | 54.26M | 46.63M | 13.16M | 61.71M | 8.11M |
| Depreciation & amortization | 25.12M | 20.38M | 22.19M | 32.21M | 25.84M | 20.82M |
| Free cash flow | 12.01M | 42.41M | 30.27M | -11.24M | 44.14M | -14.09M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.36M | 416.00K | -599.00K | 1.73M | -10.02M | -19.76M |
| Ending cash balance | 81.85M | 49.99M | 57.57M | 40.30M | 69.59M | 37.31M |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.37 | 4.32 | 4.31 | 14.00 | 4.61 | -7.62 | -3.46 | 3.51 |
| ROA %i | 1.46 | 1.78 | 1.66 | 5.54 | 1.84 | -2.95 | -1.36 | 1.48 |
| ROIC %i | 3.99 | 4.17 | 4.43 | 7.81 | 2.23 | -2.98 | -0.93 | 2.61 |
| 5-year avg ROE %i | -- | 4.04 | 4.71 | 6.84 | 6.12 | 3.92 | 2.37 | 2.21 |
| EBIT margin %i | 2.74 | 3.70 | 5.07 | 8.41 | 3.06 | -2.23 | -0.52 | 2.96 |
| FCF / sales %i | 0.14 | 3.70 | 9.24 | 7.86 | 0.28 | 2.74 | 2.09 | 3.70 |
| Current ratioi | 1.01 | 0.86 | 1.72 | 1.50 | 1.38 | 1.00 | 0.53 | 0.55 |
| Quick ratioi | 0.32 | 0.31 | 1.31 | 1.05 | 0.90 | 0.60 | 0.26 | 0.23 |
| Debt / assetsi | 34.80 | 46.90 | 44.61 | 42.44 | 43.77 | 42.49 | 40.64 | 35.02 |
| LT debt / equityi | 76.77 | 114.33 | 108.01 | 98.09 | 102.26 | 99.78 | 75.33 | 67.59 |
| Interest coveragei | 1.13 | 1.92 | 1.80 | 6.83 | 132.63 | -3.31 | -0.59 | 3.43 |
| Revenue CAGR (3Y) %i | 13.09 | 12.96 | 7.57 | 10.61 | -1.56 | 0.86 | -4.29 | 6.51 |
| Net income CAGR (3Y) %i | 87.00 | 34.96 | -5.61 | 75.68 | 8.70 | -- | -- | -11.09 |
| FCF CAGR (3Y) %i | -29.04 | 103.53 | -- | 324.59 | -55.41 | -28.32 | -38.43 | 135.12 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -3.10 | -1.67 | -0.27 | 3.51 | 5.37 | 5.75 |
| ROA %i | -1.25 | -0.69 | -0.12 | 1.48 | 2.31 | 2.54 |
| ROIC %i | -0.76 | -0.02 | 0.72 | 2.61 | 3.60 | 3.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.37 | 0.48 | 1.39 | 2.96 | 3.86 | 4.07 |
| FCF / sales %i | 2.50 | 3.01 | 4.32 | 3.70 | 5.22 | 2.41 |
| Current ratioi | 0.54 | 0.52 | 0.53 | 0.55 | 0.62 | 0.59 |
| Quick ratioi | 0.28 | 0.23 | 0.25 | 0.23 | 0.27 | 0.19 |
| Debt / assetsi | 40.05 | 36.55 | 35.41 | 35.02 | 34.26 | 35.14 |
| LT debt / equityi | 72.11 | 70.58 | 66.88 | 67.59 | 65.05 | 65.38 |
| Interest coveragei | -0.41 | 0.52 | 1.52 | 3.43 | 5.05 | 5.69 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Owned & Host is the largest reported line at 96.60% of revenue, across 3 reported segments.
- The next-largest line, Effects of unearned and deferred revenue, is a distant second at 2.45% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Owned & Host96.60%
Effects of unearned and deferred revenue2.45%
Corporate and Other0.95%
Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.